4//SEC Filing
GARDNER JASON 4
Accession 0001562180-20-000327
CIK 0001690585other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 5:01 PM ET
Size
6.7 KB
Accession
0001562180-20-000327
Insider Transaction Report
Form 4
GARDNER JASON
DirectorSee Remarks
Transactions
- Sale
Common Stock
2020-01-10$15.25/sh−11,200$170,800→ 251,212 total
Holdings
- 359,092(indirect: By Trust)
Common Stock
- 292,990(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]This trade is pursuant to an active 10b5-1 plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $15.10 to $15.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request by the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001741286
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 5:01 PM ET
- Size
- 6.7 KB